The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas (CRISPR-associated cas) systems constitute the adaptive immune system in prokaryotes, which provides resistance against bacteriophages and invasive genetic elements. The landscape of applications in bacteria and eukaryotes relies on a few Cas effector proteins that have been characterized in detail. However, there is a lack of comprehensive studies on naturally occurring CRISPR-Cas systems in beneficial bacteria, such as human gut commensal Bifidobacterium species. In this study, we mined 954 publicly available Bifidobacterium genomes and identified CRIPSR-Cas systems in 57% of these strains. A total of five CRISPR-Cas subtypes were identified as follows: Type I-E, I-C, I-G, II-A, and II-C. Among the subtypes, Type I-C was the most abundant (23%). We further characterized the CRISPR RNA (crRNA), tracrRNA, and PAM sequences to provide a molecular basis for the development of new genome editing tools for a variety of applications. Moreover, we investigated the evolutionary history of certain Bifidobacterium strains through visualization of acquired spacer sequences and demonstrated how these hypervariable CRISPR regions can be used as genotyping markers. This extensive characterization will enable the repurposing of endogenous CRISPR-Cas systems in Bifidobacteria for genome engineering, transcriptional regulation, genotyping, and screening of rare variants.
Clostridioides difficileis one of the leading causes of antibiotic-associated diarrhea. Gut microbiota-derived secondary bile acids and commensalClostridiathat encode the bile acid inducible (bai) operon are associated with protection fromC. difficileinfection (CDI), although the mechanism is not known. In this study we hypothesized that commensalClostridiaare important for providing colonization resistance againstC. difficiledue to their ability to produce secondary bile acids, as well as potentially competing againstC. difficilefor similar nutrients. To test this hypothesis, we examined the ability of four commensalClostridiaencoding thebaioperon (C. scindensVPI 12708,C. scindensATCC 35704,C. hiranonis, andC. hylemonae) to convert CA to DCAin vitro, and if the amount of DCA produced was sufficient to inhibit growth of a clinically relevantC. difficilestrain. We also investigated the competitive relationship between these commensals andC. difficileusing anin vitroco-culture system. We found that inhibition ofC. difficilegrowth by commensalClostridiasupplemented with CA was strain-dependent, correlated with the production of ∼2 mM DCA, and increased expression ofbaioperon genes. We also found thatC. difficilewas able to outcompete all four commensalClostridiain anin vitroco-culture system. These studies are instrumental in understanding the relationship between commensalClostridiaandC. difficilein the gut, which is vital for designing targeted bacterial therapeutics. Future studies dissecting the regulation of thebaioperonin vitroandin vivoand how this affects CDI will be important.Importance: CommensalClostridiaencoding thebaioperon such asC. scindenshave been associated with protection against CDI, however the mechanism for this protection is unknown. Herein, we show four commensalClostridiathat encode thebaioperon effectC. difficilegrowth in a strain-dependent manner, with and without the addition of cholate. Inhibition ofC. difficileby commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibitsC. difficilegermination, growth, and toxin production. Competition studies also revealed thatC. difficilewas able to outcompete the commensals in anin vitroco-culture system. These studies are instrumental in understanding the relationship between commensalClostridiaandC. difficilein the gut, which is vital for designing targeted bacterial therapeutics.